2010 AnnuAl REpoRT - Ciberdem

The research activity of this area is focused on the study of dyslipidaemias, metabolic syndrome and diabetic microvascular
complications. The area comprises a total of 11 research groups and includes both basic and clinical researchers. The
aim is to generate traslational collaborative research, ranging from epidemiological studies, and a global therapeutic
approach to diabetes and its complications, reaching into the area of genetic studies and the search for new biomarkers
of cardiovascular risk in diabetic subjects.
During the year 2010, the groups included in Area 2 published a total of 59 scientific papers; 22 of them were published
in journals in the first decile of the speciality. The accumulated Impact Factor (IF) for this period was 268.13. It is important
to emphasize that 9 papers were the result of collaborations between CIBERDEM research groups, and an additional 21
papers were the result of working collaborations with other groups included in different CIBER programmes. Furthermore,
groups from Area 2 were successful in obtaining 60 competitive research grants to fund their respective research projects.
Thirty of these were grants awarded jointly to different CIBERDEM groups.
In relation to other scientific activities in Area 2 during 2010, a total of 27 clinical research trials were conducted and 9
doctoral theses supervised by investigators in the Area were defended. Finally, the results of research activities were
transferred to clinical practice, with 3 new clinical guidelines being published, but there were also other important
outcomes, such as the registration of a patent and the generation of a spin-off.
Rafael Carmena
CIBERDEM Scientific Area Coordinator
2010 Annual Report
53